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postimplantation syndrome
Michiel T. Voûte, Frederico M. Bastos Gonçalves, Koen M. van de
Luijtgaarden, Casper G.A. Klein Nulent, Sanne E. Hoeks, Robert Jan Stolker,
Hence J.M. Verhagen
Objective: In patients undergoing endovascular aneurysm repair (EVAR),
the postimplantation syndrome (PIS), comprising fever and inﬂammation,
occurs frequently. The cause of PIS is unclear, but graft composition and
acute thrombus formation may play a role. The objective of this study was
to evaluate these possible causes of the inﬂammatory response after EVAR.
Methods: One hundred forty-nine patients undergoing elective EVARwere
included. Implanted stent grafts differed mainly in the type of fabric used:
either woven polyester (n = 82) or expanded polytetraﬂuorethylene
(ePTFE; n = 67). Tympanic temperature and C-reactive protein (CRP) were
assessed daily during hospitalization. PIS was deﬁned as the composite of
a body temperature of 38C coinciding with CRP >10 mg/L. Besides graft
composition, the size of the grafts and the volume of new-onset thrombus
were calculated using dedicated software, and results were correlated to
PIS.
Results: Implantation of grafts made of polyester was associated with
higher postoperative temperature (P < .001), CRP levels (P < .001), and
incidence of PIS (56.1% vs 17.9%; P < .001) compared to ePFTE. After
multivariate analysis, woven polyester stent grafts were independently
associated with an increased risk of PIS (hazard ratio, 5.6; 95% conﬁdence
interval, 1.6-19.4; P = .007). Demographics, amount of graft material
implanted, or new-onset thrombus had no association with PIS.
Conclusions: The composition of stent grafts may play a material role in
the incidence of postimplantation syndrome in patients undergoing EVAR.
Implantation of stent grafts based on woven polyester was independently
associated with a stronger inﬂammatory response.
Vascular distribution of stroke and its relationship to perioperative
mortality and neurologic outcome after thoracic endovascular aortic
repair
Brant W. Ullery, Michael McGarvey, Albert T. Cheung, Ronald M. Fairman,
Benjamin M. Jackson, Edward Y. Woo, Nimesh D. Desai, Grace J. Wang
Objective: This study assessed the vascular distribution of stroke after
thoracic endovascular aortic repair (TEVAR) and its relationship to peri-
operative death and neurologic outcome.
Methods: A retrospective review was performed for patients undergoing
TEVAR between 2001 and 2010. Aortic arch hybrid and abdominal
debranching cases were excluded. Demographics, operative variables, and
neurologic complications were examined. Stroke was deﬁned as any newq Full articles available online at www.jvascsurg.org
1078-5884/$ e see front matter
http://dx.doi.org/10.1016/S1078-5884(12)00725-3focal or global neurologic deﬁcit lasting >24 hours with radiographic
conﬁrmation of acute intracranial pathology.
Results: Perioperative stroke occurred in 20 of 530 patients (3.8%)
undergoing TEVAR. The cohort was 55% male and a mean age of 75.2  8.9
years (range, 57-90 years). Among patients with perioperative strokes, the
indication for surgery was degenerative aneurysm in 14 (mean diameter,
6.8 cm), acute type B dissection in four, penetrating atherosclerotic
aneurysm, in one, and aortic transection in one. Cases were performed
urgently or as an emergency in 60%. The proximal landing zone was zone 2
in 11 or zone 3 in nine. All strokes were embolic. The vascular distribution
of stroke involved the anterior cerebral (AC) circulation in eight (zone 2, n =
5) and the posterior cerebral (PC) circulation in 12 (zone 2, n = 6). Laterality
of cerebral infarction included ﬁve right-sided, eight left-sided, and seven
bilateral strokes. Nine strokes were diagnosed <24 hours after operation.
Therewas no difference in baseline demographics, aortic pathology, acuity,
zone coverage, preoperative left subclavian artery revascularization,
number of stents, or estimated blood loss between stroke groups based on
vascular distribution. Independent risk factors for any perioperative stroke
were chronic renal insufﬁciency (odds ratios [OR], 4.65; 95% conﬁdence
interval [CI], 1.22-17.7; P = .02) and history of prior stroke (OR, 4.92; 95% CI,
1.69-14.4; P = .004); the risk factor for AC stroke was prior stroke (OR, 7.67;
95% CI, 1.25-46.9; P = .03) and the risk factors for PC stroke were age
(OR,1.11; 95% CI,1.00-1.23; P = .04), prior stroke (OR, 7.53; 95% CI, 1.78-31.8;
P = .006), zone 2 coverage (OR, 6.11; 95% CI, 1.15-32.3; P = .03), and
penetrating atherosclerotic ulcer (OR, 32.7; 95% CI, 1.33-807.2; P = .03).
Overall in-hospital mortality was 20% (n = 4), with those sustaining PC
strokes observed to trend toward increased mortality (33% vs 0%; P = .12).
Patients with AC strokes were more likely than those with PC strokes
to achieve complete recovery of neurologic deﬁcits before discharge
(75% vs 17%; P = .02).
Conclusions: Perioperative stroke after TEVAR is primarily an embolic
event. Although infrequent, stroke was associated with signiﬁcant
morbidity and death, particularly among those with strokes involving the
PC circulation.
Predictors and outcomes of acute kidney injury after thoracic aortic
endograft repair
Gabriele Piffaretti, Giovanni Mariscalco, Stefano Bonardelli, Antonio Sar-
cina, Guido Gelpi, Raffaello Bellosta, Maurizio De Lucia, Franco Nodari,
Edoardo Cervi, Gianpaolo Carraﬁello, Carlo Antona, Patrizio Castelli
Background: This study analyzed the incidence and the predictive factors
of postoperative acute kidney injury (AKI) after thoracic endovascular
aortic repair (TEVAR) and evaluated the effect of AKI on postoperative
survival.
Methods: Between November 2000 and April 2011, all consecutive
patients undergoing TEVAR of the descending thoracic or thor-
acoabdominal aorta were enrolled at four teaching hospitals. Estimated
glomerular ﬁltration rate (eGFR) was evaluated during the entire
* A list of the members of the NCX 4016-X-208 Study Group may be found in
Appendix B (online only).
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function, End-stage renal disease) consensus criteria.
Results: The study included 171 patients (80%men)whowere amean age of
69  14 years (range, 18-87 years). AKI occurred in 24 patients (14%). Inde-
pendent predictors of postoperative AKIwere preoperative depressed eGFR,
thoracoabdominal extent, and postoperative transfusion. Patients with AKI
experienced major postoperative complications (P = .001), longer hospital-
ization (P= .008), andhigherhospitalmortality (29%vs4%;P< .001). Kaplan-
Meier analysis showed a survival of 82%, 51%, and 51% at 1, 3, and 5 years, for
patients who developed AKI, which was signiﬁcantly worse than the 99%,
89%, and 80% for patients who did not experience AKI (P = .001).
Conclusions: Preoperative poor renal function, blood transfusions, and the
thoracoabdominal extent of the aortic disease were the most important
predictors for AKI.
Temporary axillobifemoral bypass during fenestrated aortic
aneurysm repair
Jason Constantinou, Argyrios Giannopoulos, Jane Cross, Luke Morgan-
Rowe, Obiekezie Agu, Krassi Ivancev
Objective: Fenestrated endovascular aortic aneurysm repair (f-EVAR) of
juxtarenal aneurysms requiring cannulation of the superior mesenteric
artery and renal arteries is technically challenging, has a long operating
time, and requires bilateral large-caliber sheath insertion into the femoral
arteries. Consequently, the risk of lower limb ischemia and subsequent
reperfusion injury is increased. We describe the use of an adjunct
temporary axillobifemoral bypass graft (TABFBG) for f-EVAR and propose
that it be used as a strategy to avoid ischemiaereperfusion injury in
patients anticipated as being at increased risk.
Methods: Consecutive patients from a tertiary referral center undergoing
f-EVAR, between October 2008 and August 2011, were retrospectively
analyzed. Patients with lower limb arterial occlusive disease and those
with difﬁcult anatomy had an adjunct TABFBG.
Results: All patients presenting with a juxtarenal aortic aneurysm were
treated endovascularly, regardless of aneurysm anatomy and technical
difﬁculties. There were 37 patients without TABFBG (group 1) and 27 with
TABFBG (group 2). No patients required open conversion. Sex and agewere
not signiﬁcantly different between the groups. The median ankle-brachial
pressure index was signiﬁcantly higher in group 1 (P = .0001). The groups
had similar median blood loss, percentage of target vessel cannulation, and
median stay in the intensive therapy unit. Morbidities were similar in both
groups. There were no signiﬁcant differences in cardiac, renal, or respira-
tory complications between the groups. The 30-day mortality was 10.8%
(n = 4) in group 1 and 0% in group 2 (P = .046).
Conclusions: Our series has demonstrated a signiﬁcant reduction in
mortality (10.8% absolute risk reduction) and no increase in morbidity
with the use of a TABFBG for fenestrated grafts. This is likely a result of the
reduction in ischemia and ischemiaereperfusion injury in these patients.
We therefore recommend the use of TABFBG in patients with proximal
severe stenotic or occlusive disease and those in whom an operative time
of >4 hours is predicted (typically those for whom three or more target
fenestrations is planned).
Cerebral embolization in asymptomatic vs symptomatic patients
after carotid stenting
Hans H. Tulip, Eric B. Rosero, Adriana J. Higuera, Adriana Ilarraza, R. James
Valentine, Carlos H. Timaran
Background: Previous studies have investigated the development of new
ischemic brain lesions on diffusion-weighted magnetic resonance imaging
(DW-MRI) after carotid artery stenting (CAS). The rate of ischemic brain
injury after CAS for asymptomatic stenosis has not been extensively
studied, but is presumed to be less likely than in symptomatic patients.
This study assessed the occurrence of cerebral embolization after CAS for
asymptomatic vs symptomatic carotid stenosis.
Methods: During an 18-month period, 40 patients undergoing CAS under
ﬁlter embolic protection were prospectively evaluated. Transcranial
Doppler (TCD) during CAS and preprocedural and 24-hour postproceduralDW-MRI were used to assess cerebral embolization. Univariate and
nonparametric analyses were used to compare differences in cerebral
embolization after CAS in asymptomatic and symptomatic patients.
Results: CAS was performed for 23 asymptomatic (58%) and 17 symp-
tomatic (42%) carotid stenoses The median microembolic counts detected
by TCD were 285 (interquartile range [IQR], 182-376) for asymptomatic
and 313 (IQR, 170-426) for symptomatic carotid stenosis (P = .6). DW-MRI
was available for assessment in 20 asymptomatic and 14 symptomatic
patients. New acute cerebral emboli detected with DW-MRI occurred in 10
asymptomatic (50%) and 7 symptomatic patients (50%) undergoing CAS
(P = .9). The ipsilateral and total median number of DW-MRI lesions
between groups were not statistically signiﬁcantly different at, respec-
tively, 1 (IQR, 0-2.5) and 1.5 (IQR, 0-3) for asymptomatic vs 0.5 (IQR, 0-2)
and 0.5 (IQR, 0-3) for symptomatic carotid stenosis (P > .5). One asymp-
tomatic patient sustained a minor stroke after CAS. No new neurologic
events occurred in symptomatic patients. The 30-day stroke-death rate
was 2.5% in this series.
Conclusions: Cerebral embolization, as detected by TCD and DW-MRI,
occurs with a similar frequency after CAS for asymptomatic and symp-
tomatic carotid stenosis. Because postprocedural ischemic brain injury
occurs in approximately half of asymptomatic patients, the safety of CAS
under ﬁlter embolic protection for asymptomatic carotid stenosis is
uncertain and warrants further study.
Effect on walking distance and atherosclerosis progression of a nitric
oxide-donating agent in intermittent claudication
Paolo Gresele, Rino Migliacci, Enrico Arosio, Erminio Bonizzoni, Pietro
Minuz, Francesco Violi*
Background: Peripheral arterial disease (PAD) is almost invariably associ-
atedwith a generalized atherosclerotic involvement of the arterial tree and
endothelial dysfunction. Previous short-term studies showed improve-
ment of vascular reactivity and walking capacity in PAD patients by
measures aimed at restoring nitric oxide (NO) production. NO is also
known to prevent the progression of atherosclerosis. We wished to assess
whether the prolonged administration of a NO-donating agent (NCX 4016)
improves the functional capacity of PAD patients and affects the progres-
sion of atherosclerosis as assessed by carotid intima-media thickness (IMT).
Methods: This prospective, double-blind, placebo-controlled study
enrolled 442 patients with stable intermittent claudication who were
randomized to NCX 4016 (800 mg, twice daily) or its placebo for 6 months.
The primary study outcome was the absolute claudication distance on
a constant treadmill test (10% incline, 3 km/h). The main secondary end
pointwas the changeof themean far-wall right common carotid artery IMT.
Results: The increase of absolute claudication distance at 6 months
compared with baseline was 126  140 meters in the placebo-treated
group and 117  137 meters in the NCX 4016-treated group, with no
signiﬁcant differences. Carotid IMT increased in the placebo-treated group
(+0.01  0.01 mm; P = .55) and decreased in the NCX 4016etreated group
(0.03  0.01 mm; P = .0306). Other secondary end points did not differ
between the two treatments.
Conclusions: Long-term NO donation does not improve the claudication
distance but does reduce progression of atherosclerosis in patients with
PAD. Further studies aimed at assessing whether long-term NO donation
may prevent ischemic cardiovascular events are warranted.
A population-based case-control study on the association between
rheumatoid arthritis and deep vein thrombosis
Jiunn-Horng Kang, Joseph J. Keller, Yen-Kuang Lin, Herng-Ching Lin
Objective: Chronic inﬂammation has been associated with endothelial
dysfunction and altered coagulation status. However, at the present time,
the data regarding the risk for developing deep vein thrombosis (DVT) in
patients with rheumatoid arthritis (RA) is still scanty and conﬂicted. This
Abstracts / European Journal of Vascular and Endovascular Surgery 44 (2012) 598e600600study aimed to explore the frequency and association of DVTwith RA using
a population-based dataset.
Methods: This was a case-control study conducted in Taiwan. A total of
5193 patients with DVT were identiﬁed from the Longitudinal Health
Insurance Database 2000 (LHID2000) database. In total, 20,772 controls
matched with cases in terms of gender, age, and year of index date were
randomly selected. We used conditional logistic regression to calculate the
odds ratio (OR) for having been previously diagnosed with RA between
cases and controls.
Results: Of the total 25,965 sampled subjects, 235 (0.9%) had been previ-
ously diagnosed with RA. Seventy-seven of these previous diagnoses were
found among cases (1.5%) and 158 among controls (0.8%). Conditional
logistic regression analysis revealed that cases were more likely to have
had prior RA than controls (OR, 1.92; 95% conﬁdence interval [CI], 1.46-
2.53; P < .001). After adjusting for hospitalization history, pregnancy,
fracture, surgery, cancer, inﬂammatory bowel disease, heart failure,
hypertension, diabetes, coronary heart disease, hyperlipidemia, and renal
disease, there was still a signiﬁcant association between DVT and prior RA
(OR, 1.88; 95% CI, 1.42-2.58; P < .001).
Conclusions: We found RA to be signiﬁcantly associated with DVT.
Appropriate management should be taken to minimize the risk of DVT in
patients with RA. Further study is needed to conﬁrm our ﬁndings.
The inﬂuence of metabolic syndrome on hemodialysis access
patency
Clinton D. Protack, Akhilesh Jain, Penny Vasilas, Alan Dardik
Objective: The natural history of patients with metabolic syndrome (MetS)
undergoing hemodialysis access placement is unknown. MetS has previ-
ously been found as a risk factor for poor outcomes for vascular surgerypatients undergoing other interventions. The aim of this is study is to
describe the outcomes of MetS patients undergoing primary hemodialysis
access placement.
Methods: The medical records of the 187 patients who underwent
hemodialysis access placement between 1999 and 2009 at the Veterans
Administration Connecticut Healthcare System were reviewed. Survival,
primary patency, and secondary patency were evaluated using the
Gehan-Breslow test for survival. MetS was deﬁned as the presence of
three or more of the following: blood pressure 130/90 mm Hg;
triglycerides 150 mg/dL; high-density lipoprotein 50 mg/dL for
women and 40 mg/dL for men; body mass index 30 kg/m2; or fasting
blood glucose 110 mg/dL.
Results: Of the 187 patients who underwent hemodialysis access place-
ment, 115 (61%) were identiﬁed to have MetS. The distribution of MetS
factors among all patients was hypertension in 98%, diabetes in 58%,
elevated triclyceride in 39%, decreased high-density lipoprotein in 60%,
elevated body mass index in 36%, and 39% were currently receiving
hemodialysis. Patients were a mean age of 66 years. The median length of
follow-up was 4.2 years. The forearm was site of ﬁstula placement in 53%;
no difference existed between groups (MetS, 57%; no MetS, 50%; P = .388).
The median time to primary failure was 0.46 years for all patients (MetS,
0.555 years; no MetS, 0.436 years; P = .255). Secondary patency was 50% at
1.18 years for all patients (no MetS, 1.94 years; MetS, 0.72 years; P = .024).
Median survival duration for all patients was 4.15 years (no MetS, 5.07
years; MetS, 3.63 years; P = .019).
Conclusions: MetS is prevalent among patients undergoing hemodi-
alysis access placement. Patients with MetS have equivalent primary
patency rates; however, their survival and cumulative patency rates
are signiﬁcantly lower than in patients without MetS. Patients with
MetS form a high-risk group that needs intensive surveillance
protocols.
